Human Molecular Genetics, 2001, Vol. 10, No. 21 2385-2396
© 2001 Oxford University Press
Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects
Renal Division, Department of Medicine, 1Department of Pathology, Brigham and Womens Hospital, 2Department of Pathology, Childrens Hospital, Harvard Medical School, Boston, MA 02115, USA, 3Division of Nephrology, Mayo Clinic, Rochester, MN, USA and 4Institute of Molecular Medicine, University of Oxford, Oxford, UK
A high level of polycystin-1 expression is detected in kidneys of all patients with autosomal dominant polycystic kidney disease (ADPKD). Mice that overexpress polycystin-1 also develop renal cysts. Whether overexpression of polycystin-1 is necessary for cyst formation is still unclear. Here, we report the generation of a targeted mouse mutant with a null mutation in Pkd1 and its phenotypic characterization in comparison with the del34 mutants that carry a truncation mutation in Pkd1. We show that null homozygotes develop the same, but more aggressive, renal and pancreatic cystic disease as del34/del34. Moreover, we report that both homozygous mutants develop polyhydramnios, hydrops fetalis, spina bifida occulta and osteochondrodysplasia. Heterozygotes also develop adult-onset pancreatic disease. We show further that del34 homozygotes continue to produce mutant polycystin-1, thereby providing a possible explanation for increased immunoreactive polycystin-1 in ADPKD cyst epithelia in the context of the two-hit model. Our data demonstrate for the first time that loss of polycystin-1 leads to cyst formation and defective skeletogenesis, and indicate that polycystin-1 is critical in both epithelium and chondrocyte development.
+ To whom correspondence ahould be addressed at: Harvard Institutes of Medicine, Room 522, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. Tel: +1 617 525 5860; Fax: +1 617 525 5861; Email: zhou@rics.bwh.harvard.eduPresent address:Weining Lu, Genetics Division, Department of Medicine, Brigham and Womens Hospital, Boston, MA 02115, USA
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. K. Ahrabi, F. Jouret, E. Marbaix, C. Delporte, S. Horie, S. Mulroy, C. Boulter, R. Sandford, and O. Devuyst Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion Nephrol. Dial. Transplant., November 26, 2009; (2009) gfp611v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takakura, L. Contrino, X. Zhou, J. V. Bonventre, Y. Sun, B. D. Humphreys, and J. Zhou Renal injury is a third hit promoting rapid development of adult polycystic kidney disease Hum. Mol. Genet., July 15, 2009; 18(14): 2523 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Park, Y. H. Sung, M. H. Yang, J. Y. Noh, S. Y. Park, T. Y. Lee, Y. J. Yook, K. H. Yoo, K. J. Roh, I. Kim, et al. Cyst Formation in Kidney via B-Raf Signaling in the PKD2 Transgenic Mice J. Biol. Chem., March 13, 2009; 284(11): 7214 - 7222. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pei, J. Obaji, A. Dupuis, A. D. Paterson, R. Magistroni, E. Dicks, P. Parfrey, B. Cramer, E. Coto, R. Torra, et al. Unified Criteria for Ultrasonographic Diagnosis of ADPKD J. Am. Soc. Nephrol., January 1, 2009; 20(1): 205 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takakura, L. Contrino, A. W. Beck, and J. Zhou Pkd1 Inactivation Induced in Adulthood Produces Focal Cystic Disease J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2351 - 2363. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. I. Alcalay, M. Sharma, D. Vassmer, B. Chapman, B. Paul, J. Zhou, J. G. Brantley, D. P. Wallace, R. L. Maser, and G. B. Vanden Heuvel Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1 Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1725 - F1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lal, X. Song, J. L. Pluznick, V. Di Giovanni, D. M. Merrick, N. D. Rosenblum, V. Chauvet, C. J. Gottardi, Y. Pei, and M. J. Caplan Polycystin-1 C-terminal tail associates with {beta}-catenin and inhibits canonical Wnt signaling Hum. Mol. Genet., October 15, 2008; 17(20): 3105 - 3117. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fu, Y. Wang, N. Schetle, H. Gao, M. Putz, G. von Gersdorff, G. Walz, and A. G. Kramer-Zucker The Subcellular Localization of TRPP2 Modulates Its Function J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1342 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xiao, S. Zhang, B. S. Magenheimer, J. Luo, and L. D. Quarles Polycystin-1 Regulates Skeletogenesis through Stimulation of the Osteoblast-specific Transcription Factor RUNX2-II J. Biol. Chem., May 2, 2008; 283(18): 12624 - 12634. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Nauli, Y. Kawanabe, J. J. Kaminski, W. J. Pearce, D. E. Ingber, and J. Zhou Endothelial Cilia Are Fluid Shear Sensors That Regulate Calcium Signaling and Nitric Oxide Production Through Polycystin-1 Circulation, March 4, 2008; 117(9): 1161 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Natoli, T. C. Gareski, W. R. Dackowski, L. Smith, N. O. Bukanov, R. J. Russo, H. Husson, D. Matthews, P. Piepenhagen, and O. Ibraghimov-Beskrovnaya Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures Am J Physiol Renal Physiol, January 1, 2008; 294(1): F73 - F83. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Qian, R. P. Hartman, B. F. King, and V. E. Torres Increased Occurrence of Pericardial Effusion in Patients with Autosomal Dominant Polycystic Kidney Disease Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1223 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Weimbs Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1 Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1423 - F1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Leuenroth, D. Okuhara, J. D. Shotwell, G. S. Markowitz, Z. Yu, S. Somlo, and C. M. Crews Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease PNAS, March 13, 2007; 104(11): 4389 - 4394. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xiao, S. Zhang, J. Mahlios, G. Zhou, B. S. Magenheimer, D. Guo, S. L. Dallas, R. Maser, J. P. Calvet, L. Bonewald, et al. Cilia-like Structures and Polycystin-1 in Osteoblasts/Osteocytes and Associated Abnormalities in Skeletogenesis and Runx2 Expression J. Biol. Chem., October 13, 2006; 281(41): 30884 - 30895. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Nauli, S. Rossetti, R. J. Kolb, F. J. Alenghat, M. B. Consugar, P. C. Harris, D. E. Ingber, M. Loghman-Adham, and J. Zhou Loss of Polycystin-1 in Human Cyst-Lining Epithelia Leads to Ciliary Dysfunction J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1015 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Geng, D. Okuhara, Z. Yu, X. Tian, Y. Cai, S. Shibazaki, and S. Somlo Polycystin-2 traffics to cilia independently of polycystin-1 by using an N-terminal RVxP motif J. Cell Sci., April 1, 2006; 119(7): 1383 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Thivierge, A. Kurbegovic, M. Couillard, R. Guillaume, O. Cote, and M. Trudel Overexpression of PKD1 Causes Polycystic Kidney Disease Mol. Cell. Biol., February 15, 2006; 26(4): 1538 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Allen, K. B. Piontek, E. Garrett-Mayer, M. Garcia-Gonzalez, K. L. Gorelick, and G. G. Germino Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors Hum. Mol. Genet., January 1, 2006; 15(1): 11 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-T. Jiang, Y.-Y. Chiou, E. Wang, H.-K. Lin, Y.-T. Lin, Y.-C. Chi, C.-K. L. Wang, M.-J. Tang, and H. Li Defining a Link with Autosomal-Dominant Polycystic Kidney Disease in Mice with Congenitally Low Expression of Pkd1 Am. J. Pathol., January 1, 2006; 168(1): 205 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Paterson, R. Magistroni, N. He, K. Wang, A. Johnson, P. R. Fain, E. Dicks, P. Parfrey, P. St. George-Hyslop, and Y. Pei Progressive Loss of Renal Function Is an Age-Dependent Heritable Trait in Type 1 Autosomal Dominant Polycystic Kidney Disease J. Am. Soc. Nephrol., March 1, 2005; 16(3): 755 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Piontek, D. L. Huso, A. Grinberg, L. Liu, D. Bedja, H. Zhao, K. Gabrielson, F. Qian, C. Mei, H. Westphal, et al. A Functional Floxed Allele of Pkd1 that Can Be Conditionally Inactivated In Vivo J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3035 - 3043. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Cano, N. S. Murcia, G. J. Pazour, and M. Hebrok orpk mouse model of polycystic kidney disease reveals essential role of primary cilia in pancreatic tissue organization Development, July 15, 2004; 131(14): 3457 - 3467. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Guay-Woodford Murine models of polycystic kidney disease: molecular and therapeutic insights Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1034 - F1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wildman, K. M. Hooper, C. M. Turner, J. S. K. Sham, E. G. Lakatta, B. F. King, R. J. Unwin, and M. Sutters The isolated polycystin-1 cytoplasmic COOH terminus prolongs ATP-stimulated Cl- conductance through increased Ca2+ entry Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1168 - F1178. [Abstract] [Full Text] |
||||
![]() |
D. Joly, A. Hummel, A. Ruello, and B. Knebelmann Ciliary function of polycystins: a new model for cystogenesis Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1689 - 1692. [Full Text] [PDF] |
||||
![]() |
R. Magistroni, N. He, K. Wang, R. Andrew, A. Johnson, P. Gabow, E. Dicks, P. Parfrey, R. Torra, J. L. San-Millan, et al. Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1164 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Igarashi and S. Somlo Genetics and Pathogenesis of Polycystic Kidney Disease J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2384 - 2398. [Full Text] [PDF] |
||||
![]() |
M. Rodova, M. R. Islam, R. L. Maser, and J. P. Calvet The Polycystic Kidney Disease-1 Promoter Is a Target of the beta -Catenin/T-cell Factor Pathway J. Biol. Chem., August 9, 2002; 277(33): 29577 - 29583. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wu, X. Tian, S. Nishimura, G. S. Markowitz, V. D'Agati, J. Hoon Park, L. Yao, L. Li, L. Geng, H. Zhao, et al. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease Hum. Mol. Genet., August 1, 2002; 11(16): 1845 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Muto, A. Aiba, Y. Saito, K. Nakao, K. Nakamura, K. Tomita, T. Kitamura, M. Kurabayashi, R. Nagai, E. Higashihara, et al. Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant Hum. Mol. Genet., July 15, 2002; 11(15): 1731 - 1742. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rossetti, S. Burton, L. Strmecki, G. R. Pond, J. L. San Millan, K. Zerres, T. M. Barratt, S. Ozen, V. E. Torres, E. J. Bergstralh, et al. The Position of the Polycystic Kidney Disease 1 (PKD1) Gene Mutation Correlates with the Severity of Renal Disease J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1230 - 1237. [Abstract] [Full Text] [PDF] |
||||











